概括
纳普罗是一种常见的止痛药,通过取代它来降低托水平,而不是通过抑制Cox酶来降低托水平. 在小鼠中恢复托芬水平,减少了纳普洛森诱导的肠道损伤和心脏炎症.
科学领域:
- 生物化学 生物化学
- 药理学 药理学 是一个学科.
- 免疫学 免疫学 免疫学
背景情况:
- 非类固醇抗炎药物 (NSAIDs) 缓解疼痛和炎症,但会引起胃肠道和心血管方面的副作用.
- 传统的NSAID和选择性循环氧化酶-2 (COX-2) 抑制剂,如赛莱科西布,具有不同的安全性.
- 不完全理解NSAID诱导的副作用背后的精确机制.
研究的目的:
- 为了比较纳普罗和塞莱科西布在人类和小鼠中的作用.
- 调查纳普洛森对托芬和金林水平的影响.
- 阐明纳普罗诱导的三抑郁症的机制及其在副作用中的作用.
主要方法:
- 人类志愿者接受了纳普洛克森治疗,并测量了托和金林的血水平.
- 实验在小鼠中复制,以验证人类的发现.
- 在小鼠身上进行的研究探讨了COX-1和COX-2抑制与托芬排位的作用.
- 在小鼠中使用了托芬补充剂,以评估其对纳普罗诱导的副作用的影响.
主要成果:
- 在人类和小鼠中,纳普洛克森治疗导致了血三甲和金林水平的降低.
- 托芬抑郁是由于纳普罗森取代结合的托芬,独立于COX-1或COX-2抑制.
- 在小鼠中服用托芬补充剂减轻了纳普罗森诱导的便失血.
- 恢复托水平也减少了IL-1β驱动的炎症基因表达在心脏.
结论:
- 纳普洛克森降低托芬水平的机制涉及排位,而不是COX抑制.
- 这种托耗尽可能导致NSAID相关的胃肠道和心血管不良影响.
- 托芬补充剂显示出作为一种治疗策略来抵消纳普罗的副作用的潜力.
相关概念视频
Drug Metabolism: Phase II Reactions
3.6K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.6K
Drug Metabolism: Phase I Reactions
3.1K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
Inflammatory Response
1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95


